Globe Life (GL) Projected to Post Quarterly Earnings on Wednesday

Globe Life (NYSE:GL) is anticipated to post its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $3.44 per share and revenue of $1.5319 billion for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 11:00 AM ET.

Globe Life Price Performance

Shares of GL opened at $137.23 on Wednesday. Globe Life has a fifty-two week low of $109.38 and a fifty-two week high of $147.83. The firm’s 50-day simple moving average is $137.83 and its two-hundred day simple moving average is $136.95. The stock has a market cap of $10.92 billion, a PE ratio of 9.94 and a beta of 0.48. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Monday, January 5th will be paid a $0.27 dividend. The ex-dividend date is Monday, January 5th. This represents a $1.08 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio is presently 7.83%.

Analyst Ratings Changes

A number of research firms recently weighed in on GL. Piper Sandler reaffirmed an “overweight” rating and set a $167.00 price objective on shares of Globe Life in a research report on Friday, November 21st. TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Evercore ISI cut shares of Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price target on the stock. in a research note on Tuesday, January 6th. Weiss Ratings lowered shares of Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, January 14th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Seven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $166.22.

Insider Transactions at Globe Life

In other news, CEO Frank M. Svoboda sold 9,379 shares of Globe Life stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the sale, the chief executive officer directly owned 35,868 shares in the company, valued at $5,036,943.24. The trade was a 20.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.97% of the company’s stock.

Institutional Investors Weigh In On Globe Life

A number of large investors have recently added to or reduced their stakes in the stock. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life during the 2nd quarter valued at $28,000. MUFG Securities EMEA plc purchased a new position in Globe Life in the second quarter worth about $31,000. Banque Cantonale Vaudoise purchased a new stake in shares of Globe Life during the 3rd quarter valued at about $50,000. Advisory Services Network LLC bought a new stake in Globe Life during the third quarter valued at approximately $72,000. Finally, Johnson Financial Group Inc. increased its holdings in Globe Life by 272.6% during the third quarter. Johnson Financial Group Inc. now owns 734 shares of the company’s stock valued at $105,000 after buying an additional 537 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.